BIO vs TSE · rev $651.0M vs rev $3.51B
BIO (BIO) versus Trinseo SA (TSE) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Trinseo SA (TSE) is a specialty chemicals company listed on NYSE.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported TSE revenue for 2024-12-31 was $3.51B. Net income was -$348.5M. Revenue was down 4.4% from 2023-12-31 to 2024-12-31. TSE currently screens at market cap $8.3M.
BIO currently screens at market cap $0. TSE currently screens at market cap $8.3M.
Not investment advice. Open the BIO and TSE stock pages for the full models.
Not investment advice.